|

KOrean Borderline Ovarian Tumor (KOBOT) Registry

RECRUITINGSponsored by Kangbuk Samsung Hospital
Actively Recruiting
SponsorKangbuk Samsung Hospital
Started1994-12
Est. completion2040-12
Eligibility
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT02803970

Summary

The aim of this study is to collect data on Korean patients with borderline ovarian tumors.

Eligibility

Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Patients with borderline ovarian tumors (BOTs) diagnosed, treated, and followed between November 1994 and February 2015 at institutions where placed in the Republic of Korea.
* All patients undergoing gynecologic surgery for BOTs at institutions where placed in the Republic of Korea since March, 2015

Exclusion Criteria:

* Patients who did not receive primary treatment or follow-up for at least 6 months at each institution were excluded from analysis

Conditions2

CancerOvarian Neoplasms

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.